Advertisement

Azole Antifungals - Biotech, Pharma and Life Science Channel

04:45 EDT 20th June 2013 | BioPortfolio

PubMed Articles [ 170 Associated PubMed Articles listed on BioPortfolio]

New azole antagonists with high affinity for the P2Y1 receptor.

Five-membered-ring heterocyclic urea mimics have been found to be potent and selective antagonists of the P2Y1 receptor. SAR of the various heterocyclic replacements is presented, as well as side-chai...

Carbonic anhydrase inhibitors. Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase.

A series of benzenesulfonamides incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the β-carbonic anhydrase (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScC...

Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.

Invasive fungal infections have increased significantly in the past few decades because of the increase in high-risk populations. To investigate the distribution and drug susceptibilities of such infe...

Synthesis, physical properties and self-assembly behavior of azole-fused pyrene derivatives.

A novel selenadiazole-fused pyrene derivative was successfully synthesized and characterized. Its single structure is almost planar and adopts a sandwich-herringbone packing model. The self-assembly b...

Proteomic survey of the Streptomyces coelicolor nucleoid.

Nucleoid-associated proteins (NAPs) are small, highly abundant transcriptional regulators with low sequence specificity which are involved in multiple DNA-related processes including gene expression,...

The Antifungal Occidiofungin Triggers an Apoptotic Mechanism of Cell Death in Yeast.

Occidiofungin is a nonribosomally synthesized cyclic peptide having a base mass of 1200 Da. It is naturally produced by the soil bacterium Burkholderia contaminans MS14 and possesses potent broad-spec...

A Quantitative Analysis of the Spontaneous Reporting of Congestive Heart Failure-Related Adverse Events With Systemic Anti-Fungal Drugs.

To investigate spontaneous reporting relationships between representative antifungal agents and congestive heart failure (CHF)-related adverse events (AE) we performed multiple disproportionality anal...

A Nanoelectrospray Ionisation Mass Spectrometric Study of Mycobacterium tuberculosis CYP121-Ligand Interactions.

Nanoelectrospray ionisation mass spectrometry (nanoESI MS) of intact protein complexes was used to study CYP121, one of the twenty cytochrome P450s in Mycobacterium tuberculosis (Mtb) and an enzyme th...

Environmental study of azole-resistant Aspergillus fumigatus with TR34 /L98H mutations in the cyp51A gene in Iran.

Azole resistance in Aspergillus is emerging in European and Asian countries. As azoles are mainstay of therapy in the management of aspergillosis, azole resistance has serious implications in patient...

Simple heteroatom engineering for tuning the triplet energy of organometallic host materials for red, green and blue phosphorescent organic light-emitting diodes.

Triplet energy tuning from 2.48 eV to 2.94 eV by just a simple change of heteroatom in the ligand structure of Be complexes was studied using azole based triplet host materials. Three Be organometalli...

News Articles [ 14 Associated News Articles listed on BioPortfolio]

Novo A/S acquires Xellia

Novo A/S (Hellerup, Denmark) will acquire infectious disease company Xellia Pharmaceuticals A/S (Oslo, Norway) from private equity firm 3i Group for about $700 million. In 2008, 3i acquired Xellia, wh...

No Clear Favorite for Topical Treatment of Dermatophytosis

Most antifungals provide mycologic cure of dermatophytosis, although maintenance of cure may be best with butenafine or amorolfine, researchers from Brazil report. Reuters Health Information

Growing Technology Commercialization: University of Kansas Moving Innovation from the Laboratory to the Marketplace

Lawrence, KS, March 26, 2013 --(PR.com)-- The University of Kansas continues to move innovations from the laboratory to the marketplace. As part of this effort, five KU researchers have been awarded...

Blog Syn: An Idea Whose Time Has Come?

Here's something I've been following for the last couple of weeks in the chemical blogging world, and now it's up on its own site: "Blog Syn", an initiative of the well-known chemblogger See Arr Oh. T...

Combined fluoroquinolone and azole use associated with QT prolongation

NEW YORK (Reuters Health) - One in five hematology patients treated with a fluoroquinolone-azole combination may develop significant QT prolongation, Mayo Clinic researchers report.

MethylGene Completes Enrollment in Phase II Trial of MGCD290

MONTREAL, CANADA -- (Marketwire) -- 12/19/12 -- MethylGene Inc. (TSX: MYG) today announced that it has completed enrollment in its multi-center, randomized, double-blind, placebo-controlled trial (Tr...

Merz, Inc. Announces the Completion of the Acquisition of ONMEL™ Oral Treatment for Fungal Infections of the Toenail in Patients with a Normal Immune System

Merz, Inc. (U.S. affiliate of Merz Pharma Group) today announced the completion of the acquisition of ONMEL™ (itraconazole), an azole antifungal that is indicated for the oral t...

Vr Laboratories Selects Hsg2001 As Lead Development Candidate For Candida Albicans Program

Bonita Springs, Fla., Nov. 16, 2012 /PRNewswire-iReach/ -- VR Laboratories LLC today announced they have selected a lead product candidate based on preclinical activity to target Candida albicans (C....

Ashworth College Launches Certified Pharmacy Technician Career Training Program

Ashworth College announced the addition of Certified Pharmacy Technician (http://www.ashworthcollege.edu/) to its roster of online career training programs. At the conclusion of the program, graduates...

Ferrer takes novel antifungal into Phase III

The private Spanish pharmaceutical company Ferrer is to begin a Phase III study early next year for what it hopes will be a best–in-class topical azole antifungal, arasertaconazole, for vulvovag...

Events [0 Results]

None

Companies [ 1 Associated Companies listed on BioPortfolio]

Arlington Medical Resources

AMR's Hospital Anti-Infectives Insight Series: Gram-Negative Infections analyzes hospital antifungal prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction wit...

Clinical Trials [ 11 Associated Clinical Trials listed on BioPortfolio]

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

RATIONALE: Antifungals, such as caspofungin acetate, may be effective in treating fungal infections caused by chemotherapy or stem cell transplant. PURPOSE: This phase II trial is studyin...

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

RATIONALE: Antifungals, such as voriconazole and itraconazole, may be effective in preventing fungal infections in patients who are undergoing allogeneic stem cell transplantation....

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis

Invasive aspergillosis is a type of fungal infection typically identified in very sick patients (for example, patients with cancer or who have had a bone marrow or organ transplant). This...

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

RATIONALE: Antifungals such as ravuconazole may be effective in preventing fungal infections in patients undergoing chemotherapy and stem cell transplantation. PURPOSE: Phase I/II trial t...

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Invasive fungal infections are often life-threatening in persons with immunocompromise. Persons with prolonged neutropenia secondary to cytotoxic chemotherapies are at high risk for these...

Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis

Invasive aspergillosis is a fungal disease which is increasing in incidence with the increase in immunocompromised persons in our population. Persons with prolonged neutropenia secondary...

Antifungal Use in Oncohematological Neutropenic Patients

Primary purpose: Frequency of use of broad-spectrum antifungals in the episode of neutropenia. Secondary purposes:To determine the safety and toxicity measure by: 1. Frequency of...

A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT

Objectives Primary Objectives: - Pilot Study: A preliminary assessment of the exposure and safety of oral A-60444 in post-stem cell transplant patients with RSV infection....

Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia

Empirical antifungal treatment is the gold standard for patients who are neutropenic and have persistent fever under broad-spectrum antibiotics. The rational is that fungal infections are...

The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)

Anidulafungin is an antifungal agent of the echinocandin class which is highly active in vitro against fluconazole resistant Candida species. The efficacy of anidulafungin has demonstrated...

Medical and Biotech [MESH] Definitions

14-alpha Demethylase Inhibitors

Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism.

Search BioPortfolio:
Advertisement
review and buy Azole Antifungals market research data and corporate reports here

Channels Quicklinks

Advertisement